Skip to main content
Top
Published in: Journal of Translational Medicine 1/2009

Open Access 01-12-2009 | Research

An intron 9 containing splice variant of PAX2

Authors: Antonia Busse, Anika Rietz, Stefan Schwartz, Eckhard Thiel, Ulrich Keilholz

Published in: Journal of Translational Medicine | Issue 1/2009

Login to get access

Abstract

Background

PAX2 is a transcription factor with an important role in embryogenic development. However, PAX2 expression was frequently identified in neoplasia responsible for the growth and survival of cancer cells. Due to alternative splicing of exon 6, exon 10 and exon 12 four isoforms of PAX2 are described so far.

Methods

The expression of an intron 9 containing PAX2 splice variant was analyzed in neoplastic B cell and solid tumor cell lines as well as in primary tumor samples by quantitative RT-PCR. PAX2 proteins were detected by Western Blot in a subset of cell lines.

Results

All 14 lymphoma cell lines expressed an undescribed PAX2 splice variant containing the entire intron 9 sequence and the exon 10 sequence. This splice variant could also be detected in 35 solid tumor cell lines, in leukemia and lymphoma as well as in colon carcinoma and melanoma patient samples and in blood samples of healthy donors. Expression of this new splice variant on protein level was verified by Western Blot analysis.

Conclusion

We discovered a previously undescribed intron 9 and exon 10 containing splice variant of PAX2 in B-cell neoplasia and in solid tumors on mRNA and protein level.
Appendix
Available only for authorised users
Literature
1.
go back to reference Strachan T, Read AP: PAX genes. Curr Opin Genet Dev. 1994, 4: 427-438. 10.1016/0959-437X(94)90032-9.CrossRefPubMed Strachan T, Read AP: PAX genes. Curr Opin Genet Dev. 1994, 4: 427-438. 10.1016/0959-437X(94)90032-9.CrossRefPubMed
2.
go back to reference Treisman J, Harris E, Desplan C: The paired box encodes a second DNA-binding domain in the paired homeo domain protein. Genes Dev. 1991, 5: 594-604. 10.1101/gad.5.4.594.CrossRefPubMed Treisman J, Harris E, Desplan C: The paired box encodes a second DNA-binding domain in the paired homeo domain protein. Genes Dev. 1991, 5: 594-604. 10.1101/gad.5.4.594.CrossRefPubMed
3.
go back to reference Robson EJ, He SJ, Eccles MR: A PANorama of PAX genes in cancer and development. Nat Rev Cancer. 2006, 6: 52-62. 10.1038/nrc1778.CrossRefPubMed Robson EJ, He SJ, Eccles MR: A PANorama of PAX genes in cancer and development. Nat Rev Cancer. 2006, 6: 52-62. 10.1038/nrc1778.CrossRefPubMed
4.
go back to reference Sanyanusin P, Norrish JH, Ward TA, Nebel A, McNoe LA, Eccles MR: Genomic structure of the human PAX2 gene. Genomics. 1996, 35: 258-261. 10.1006/geno.1996.0350.CrossRefPubMed Sanyanusin P, Norrish JH, Ward TA, Nebel A, McNoe LA, Eccles MR: Genomic structure of the human PAX2 gene. Genomics. 1996, 35: 258-261. 10.1006/geno.1996.0350.CrossRefPubMed
5.
go back to reference Eccles MR, He S, Legge M, Kumar R, Fox J, Zhou C, French M, Tsai RW: PAX genes in development and disease: the role of PAX2 in urogenital tract development. Int J Dev Biol. 2002, 46: 535-544.PubMed Eccles MR, He S, Legge M, Kumar R, Fox J, Zhou C, French M, Tsai RW: PAX genes in development and disease: the role of PAX2 in urogenital tract development. Int J Dev Biol. 2002, 46: 535-544.PubMed
6.
go back to reference Lang D, Powell SK, Plummer RS, Young KP, Ruggeri BA: PAX genes: roles in development, pathophysiology, and cancer. Biochem Pharmacol. 2007, 73: 1-14. 10.1016/j.bcp.2006.06.024.CrossRefPubMed Lang D, Powell SK, Plummer RS, Young KP, Ruggeri BA: PAX genes: roles in development, pathophysiology, and cancer. Biochem Pharmacol. 2007, 73: 1-14. 10.1016/j.bcp.2006.06.024.CrossRefPubMed
7.
go back to reference Muratovska A, Zhou C, He S, Goodyer P, Eccles MR: Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene. 2003, 22: 7989-7997. 10.1038/sj.onc.1206766.CrossRefPubMed Muratovska A, Zhou C, He S, Goodyer P, Eccles MR: Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene. 2003, 22: 7989-7997. 10.1038/sj.onc.1206766.CrossRefPubMed
8.
go back to reference Ozcan A, Zhai J, Hamilton C, Shen SS, Ro JY, Krishnan B, Truong LD: PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin. Am J Clin Pathol. 2009, 131: 393-404. 10.1309/AJCPM7DW0XFHDHNY.CrossRefPubMed Ozcan A, Zhai J, Hamilton C, Shen SS, Ro JY, Krishnan B, Truong LD: PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin. Am J Clin Pathol. 2009, 131: 393-404. 10.1309/AJCPM7DW0XFHDHNY.CrossRefPubMed
9.
go back to reference Buttiglieri S, Deregibus MC, Bravo S, Cassoni P, Chiarle R, Bussolati B, Camussi G: Role of Pax2 in apoptosis resistance and proinvasive phenotype of Kaposi's sarcoma cells. J Biol Chem. 2004, 279: 4136-4143. 10.1074/jbc.M306824200.CrossRefPubMed Buttiglieri S, Deregibus MC, Bravo S, Cassoni P, Chiarle R, Bussolati B, Camussi G: Role of Pax2 in apoptosis resistance and proinvasive phenotype of Kaposi's sarcoma cells. J Biol Chem. 2004, 279: 4136-4143. 10.1074/jbc.M306824200.CrossRefPubMed
10.
go back to reference Gnarra JR, Dressler GR: Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. Cancer Res. 1995, 55: 4092-4098.PubMed Gnarra JR, Dressler GR: Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. Cancer Res. 1995, 55: 4092-4098.PubMed
11.
go back to reference Asemissen AM, Haase D, Stevanovic S, Bauer S, Busse A, Thiel E, Rammensee HG, Keilholz U, Scheibenbogen C: Identification of an immunogenic HLA-A*0201-binding T-cell epitope of the transcription factor PAX2. J Immunother. 2009, 32: 370-375. 10.1097/CJI.0b013e31819d4e09.CrossRefPubMed Asemissen AM, Haase D, Stevanovic S, Bauer S, Busse A, Thiel E, Rammensee HG, Keilholz U, Scheibenbogen C: Identification of an immunogenic HLA-A*0201-binding T-cell epitope of the transcription factor PAX2. J Immunother. 2009, 32: 370-375. 10.1097/CJI.0b013e31819d4e09.CrossRefPubMed
12.
go back to reference Dehbi M, Ghahremani M, Lechner M, Dressler G, Pelletier J: The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1). Oncogene. 1996, 13: 447-453.PubMed Dehbi M, Ghahremani M, Lechner M, Dressler G, Pelletier J: The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1). Oncogene. 1996, 13: 447-453.PubMed
13.
go back to reference Silberstein GB, Dressler GR, Van Horn K: Expression of the PAX2 oncogene in human breast cancer and its role in progesterone-dependent mammary growth. Oncogene. 2002, 21: 1009-1016. 10.1038/sj.onc.1205172.CrossRefPubMed Silberstein GB, Dressler GR, Van Horn K: Expression of the PAX2 oncogene in human breast cancer and its role in progesterone-dependent mammary growth. Oncogene. 2002, 21: 1009-1016. 10.1038/sj.onc.1205172.CrossRefPubMed
14.
go back to reference Khoubehi B, Kessling AM, Adshead JM, Smith GL, Smith RD, Ogden CW: Expression of the developmental and oncogenic PAX2 gene in human prostate cancer. J Urol. 2001, 165: 2115-2120. 10.1016/S0022-5347(05)66304-5.CrossRefPubMed Khoubehi B, Kessling AM, Adshead JM, Smith GL, Smith RD, Ogden CW: Expression of the developmental and oncogenic PAX2 gene in human prostate cancer. J Urol. 2001, 165: 2115-2120. 10.1016/S0022-5347(05)66304-5.CrossRefPubMed
15.
go back to reference Siehl JM, Thiel E, Heufelder K, Snarski E, Schwartz S, Mailander V, Keilholz U: Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias. Br J Haematol. 2003, 123: 235-242. 10.1046/j.1365-2141.2003.04622.x.CrossRefPubMed Siehl JM, Thiel E, Heufelder K, Snarski E, Schwartz S, Mailander V, Keilholz U: Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias. Br J Haematol. 2003, 123: 235-242. 10.1046/j.1365-2141.2003.04622.x.CrossRefPubMed
16.
go back to reference Tamimi Y, Ekuere U, Laughton N, Grundy P: WNT5A is regulated by PAX2 and may be involved in blastemal predominant Wilms tumorigenesis. Neoplasia. 2008, 10: 1470-1480.PubMedCentralCrossRefPubMed Tamimi Y, Ekuere U, Laughton N, Grundy P: WNT5A is regulated by PAX2 and may be involved in blastemal predominant Wilms tumorigenesis. Neoplasia. 2008, 10: 1470-1480.PubMedCentralCrossRefPubMed
17.
go back to reference Bose SK, Gibson W, Bullard RS, Donald CD: PAX2 oncogene negatively regulates the expression of the host defense peptide human beta defensin-1 in prostate cancer. Mol Immunol. 2009, 46: 1140-1148. 10.1016/j.molimm.2008.11.004.PubMedCentralCrossRefPubMed Bose SK, Gibson W, Bullard RS, Donald CD: PAX2 oncogene negatively regulates the expression of the host defense peptide human beta defensin-1 in prostate cancer. Mol Immunol. 2009, 46: 1140-1148. 10.1016/j.molimm.2008.11.004.PubMedCentralCrossRefPubMed
18.
go back to reference Dressler GR, Douglass EC: Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci USA. 1992, 89: 1179-1183. 10.1073/pnas.89.4.1179.PubMedCentralCrossRefPubMed Dressler GR, Douglass EC: Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci USA. 1992, 89: 1179-1183. 10.1073/pnas.89.4.1179.PubMedCentralCrossRefPubMed
19.
go back to reference Ward TA, Nebel A, Reeve AE, Eccles MR: Alternative messenger RNA forms and open reading frames within an additional conserved region of the human PAX-2 gene. Cell Growth Differ. 1994, 5: 1015-1021.PubMed Ward TA, Nebel A, Reeve AE, Eccles MR: Alternative messenger RNA forms and open reading frames within an additional conserved region of the human PAX-2 gene. Cell Growth Differ. 1994, 5: 1015-1021.PubMed
20.
go back to reference Tavassoli K, Ruger W, Horst J: Alternative splicing in PAX2 generates a new reading frame and an extended conserved coding region at the carboxy terminus. Hum Genet. 1997, 101: 371-375. 10.1007/s004390050644.CrossRefPubMed Tavassoli K, Ruger W, Horst J: Alternative splicing in PAX2 generates a new reading frame and an extended conserved coding region at the carboxy terminus. Hum Genet. 1997, 101: 371-375. 10.1007/s004390050644.CrossRefPubMed
21.
go back to reference Smith CW, Patton JG, Nadal-Ginard B: Alternative splicing in the control of gene expression. Annu Rev Genet. 1989, 23: 527-577. 10.1146/annurev.ge.23.120189.002523.CrossRefPubMed Smith CW, Patton JG, Nadal-Ginard B: Alternative splicing in the control of gene expression. Annu Rev Genet. 1989, 23: 527-577. 10.1146/annurev.ge.23.120189.002523.CrossRefPubMed
22.
go back to reference Lechner MS, Dressler GR: Mapping of Pax-2 transcription activation domains. J Biol Chem. 1996, 271: 21088-21093. 10.1074/jbc.271.35.21088.CrossRefPubMed Lechner MS, Dressler GR: Mapping of Pax-2 transcription activation domains. J Biol Chem. 1996, 271: 21088-21093. 10.1074/jbc.271.35.21088.CrossRefPubMed
Metadata
Title
An intron 9 containing splice variant of PAX2
Authors
Antonia Busse
Anika Rietz
Stefan Schwartz
Eckhard Thiel
Ulrich Keilholz
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2009
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-7-36

Other articles of this Issue 1/2009

Journal of Translational Medicine 1/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.